Close search filters
Changing filters will change the listed Success Criteria and Techniques
Category
Topic
Search results (27)
Article
Gene therapies 101
February 12, 2020
We answer our clients’ burning questions about gene therapies, including how they work, whether or not they’re safe, and if we’ll see more in the future.
Article
Understanding gene modification and cellular therapies
June 02, 2021
Gene modification and cellular therapies are unique, potentially curative treatments that leverage gene-altering technology
Article
The future of gene therapy
October 20, 2023
Recent research suggests that the number of gene therapies on the market is likely to increase to over 60 by 2030. As rapid advancements in the field continue, here is what plan sponsors can expect to...
Article
Copay Assistance Strategy Reduces Financial Burdens for Plans And Patients
October 07, 2021
Innovative solution provides $0 member cost for costly specialty drugs while reducing plans’ costs
Article
How to have a data-driven discussion on gene and cellular therapies
October 28, 2021
As the number of approved gene and cellular therapies grows, you can start preparing your organization now by taking the right next steps.
Article
Three specialty drug trends to prepare for: Biosimilars, gene and cell therapies, cancer drugs
April 20, 2022
Biosimilars, gene and cell therapies, and cancer drugs are filling the specialty pipeline. Here are some insights for each category to help you stay informed.
This topic was the focus of a breakout...
Article
Uncovering behind-the-scenes challenges in bringing gene therapies to market
June 07, 2022
Patients getting access to expensive gene therapies is just one of the many challenges to bringing these sometimes life-saving drugs to market.
Video
Biosimilar Approval and Adoption Challenges
June 10, 2022
Accelerating the progress of biosimilars is key to lowering drug costs and improving patient access to potentially life-saving therapies.
Article
Simplifying medical benefit drug management complexities
An integrated approach to managing medically billed specialty drugs is key to optimizing cost savings and clinical outcomes.
Read MoreArticle
Two Ways to Assess the Holistic Value of Your Specialty Partner
October 06, 2022
Getting the most value out of your specialty drug management partner starts with asking the right questions.